Literature DB >> 28684316

Regulation of calcium release from the endoplasmic reticulum by the serine hydrolase ABHD2.

Bogeon Yun1, HeeJung Lee1, Roger Powell2, Nichole Reisdorph2, Heather Ewing3, Michael H Gelb3, Ku-Lung Hsu4, Benjamin F Cravatt5, Christina C Leslie6.   

Abstract

The serine hydrolase inhibitors pyrrophenone and KT195 inhibit cell death induced by A23187 and H2O2 by blocking the release of calcium from the endoplasmic reticulum and mitochondrial calcium uptake. The effect of pyrrophenone and KT195 on these processes is not due to inhibition of their known targets, cytosolic phospholipase A2 and α/β-hydrolase domain-containing (ABHD) 6, respectively, but represent off-target effects. To identify targets of KT195, fibroblasts were treated with KT195-alkyne to covalently label protein targets followed by click chemistry with biotin azide, enrichment on streptavidin beads and tryptic peptide analysis by mass spectrometry. Although several serine hydrolases were identified, α/β-hydrolase domain-containing 2 (ABHD2) was the only target in which both KT195 and pyrrophenone competed for binding to KT195-alkyne. ABHD2 is a serine hydrolase with a predicted transmembrane domain consistent with its pull-down from the membrane proteome. Subcellular fractionation showed localization of ABHD2 to the endoplasmic reticulum but not to mitochondria or mitochondrial-associated membranes. Knockdown of ABHD2 with shRNA attenuated calcium release from the endoplasmic reticulum, mitochondrial calcium uptake and cell death in fibroblasts stimulated with A23187. The results describe a novel mechanism for regulating calcium transfer from the endoplasmic reticulum to mitochondria that involves the serine hydrolase ABHD2.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABHD2; Calcium; Cell death; Endoplasmic reticulum; H(2)O(2); Mitochondria; Pyrrophenone; Serine hydrolase

Mesh:

Substances:

Year:  2017        PMID: 28684316      PMCID: PMC5658124          DOI: 10.1016/j.bbrc.2017.06.195

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  51 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 2.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 3.  Intracellular Ca(2+) signaling and Ca(2+) microdomains in the control of cell survival, apoptosis and autophagy.

Authors:  Rita M L La Rovere; Gemma Roest; Geert Bultynck; Jan B Parys
Journal:  Cell Calcium       Date:  2016-04-20       Impact factor: 6.817

4.  Enzymatic properties of human cytosolic phospholipase A(2)gamma.

Authors:  Allison Stewart; Moumita Ghosh; Diane M Spencer; Christina C Leslie
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

5.  A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.

Authors:  Andrew P Halestrap
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

6.  Cloning and tissue distribution of three murine alpha/beta hydrolase fold protein cDNAs.

Authors:  Alasdair J Edgar; Julia M Polak
Journal:  Biochem Biophys Res Commun       Date:  2002-04-05       Impact factor: 3.575

Review 7.  Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.

Authors:  Paolo Bernardi; Paolo Bonaldo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

8.  Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

Authors:  I P Street; H K Lin; F Laliberté; F Ghomashchi; Z Wang; H Perrier; N M Tremblay; Z Huang; P K Weech; M H Gelb
Journal:  Biochemistry       Date:  1993-06-15       Impact factor: 3.162

9.  Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA.

Authors:  Junji Suzuki; Kazunori Kanemaru; Kuniaki Ishii; Masamichi Ohkura; Yohei Okubo; Masamitsu Iino
Journal:  Nat Commun       Date:  2014-06-13       Impact factor: 14.919

10.  A mitochondrial kinase complex is essential to mediate an ERK1/2-dependent phosphorylation of a key regulatory protein in steroid biosynthesis.

Authors:  Cecilia Poderoso; Daniela P Converso; Paula Maloberti; Alejandra Duarte; Isabel Neuman; Soledad Galli; Fabiana Cornejo Maciel; Cristina Paz; María C Carreras; Juan J Poderoso; Ernesto J Podestá
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

View more
  6 in total

Review 1.  Reactive chemistry for covalent probe and therapeutic development.

Authors:  R Justin Grams; Ku-Lung Hsu
Journal:  Trends Pharmacol Sci       Date:  2022-01-06       Impact factor: 14.819

Review 2.  Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease.

Authors:  Jun Xu; Weizhen Gu; Kai Ji; Zhao Xu; Haihua Zhu; Wenming Zheng
Journal:  Open Biol       Date:  2018-05       Impact factor: 6.411

3.  miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.

Authors:  Yuanmin He; Yan Yang; Yongmei Liao; Jixiang Xu; Li Liu; Changqiang Li; Xia Xiong
Journal:  Mol Ther Oncolytics       Date:  2020-03-30       Impact factor: 7.200

4.  Progesterone activates the cyclic AMP-protein kinase A signalling pathway by upregulating ABHD2 in fertile men.

Authors:  Feng Jiang; Yong Zhu; Ying Chen; Xiaofeng Tang; Liu Liu; Guowu Chen; Yulin Liu; Xiaoxi Sun
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer.

Authors:  Hui Wang; Hui Hu; Zhenzhao Luo; Shuiyi Liu; Wangze Wu; Man Zhu; Jing Wang; Yingle Liu; Zhongxin Lu
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

6.  Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset.

Authors:  Jingjing Li; Yan Li; Xiaoshun He; Qiang Zhao
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.